Article Details
Retrieved on: 2022-10-31 11:57:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Inc.'s Inmazeb (consisting of the monoclonal antibodies atoltivimab, ... on decades of deep investment in our enabling antibody technologies.”.
Article found on: pharmaphorum.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here